XML 35 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
FAIR VALUE MEASUREMENTS (Details Textual) (USD $)
1 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2011
Jun. 30, 2012
Dec. 29, 2011
Dec. 31, 2010
Manhattan And Ariston Pharmaceuticals Merger [Member]
Notes Issued       $ 15,452,793
Debt Instrument, Maturity Period       5 years
Debt Instrument, Interest Rate, Effective Percentage       5.00%
Debt Instrument, Convertible, Conversion Price       $ 1,125
Percentage Of Cash Proceeds From Operation To Repay Interest On Convertible Debt       50.00%
Long-term Debt, Gross 16,883,000 17,302,000 16,876,000  
Debt Instrument, Fair Value Disclosure   4,664,697    
Fair Value Inputs, Discount Rate 20.00% 20.00%    
Repayments of Long-term Debt   $ 0